37129835|t|Posttreatment with Ospemifene Attenuates Hypoxia- and Ischemia-Induced Apoptosis in Primary Neuronal Cells via Selective Modulation of Estrogen Receptors.
37129835|a|Stroke and perinatal asphyxia have detrimental effects on neuronal cells, causing millions of deaths worldwide each year. Since currently available therapies are insufficient, there is an urgent need for novel neuroprotective strategies to address the effects of cerebrovascular accidents. One such recent approach is based on the neuroprotective properties of estrogen receptors (ERs). However, activation of ERs by estrogens may contribute to the development of endometriosis or hormone-dependent cancers. Therefore, in this study, we utilized ospemifene, a novel selective estrogen receptor modulator (SERM) already used in dyspareunia treatment. Here, we demonstrated that posttreatment with ospemifene in primary neocortical cell cultures subjected to 18 h of hypoxia and/or ischemia followed by 6 h of reoxygenation has robust neuroprotective potential. Ospemifene partially reverses hypoxia- and ischemia-induced changes in LDH release, the degree of neurodegeneration, and metabolic activity. The mechanism of the neuroprotective actions of ospemifene involves the inhibition of apoptosis since the compound decreases caspase-3 overactivity during hypoxia and enhances mitochondrial membrane potential during ischemia. Moreover, in both models, ospemifene decreased the levels of the proapoptotic proteins BAX, FAS, FASL, and GSK3beta while increasing the level of the antiapoptotic protein BCL2. Silencing of specific ERs showed that the neuroprotective actions of ospemifene are mediated mainly via ESR1 (during hypoxia and ischemia) and GPER1 (during hypoxia), which is supported by ospemifene-evoked increases in ESR1 protein levels in hypoxic and ischemic neurons. The results identify ospemifene as a promising neuroprotectant, which in the future may be used to treat injuries due to brain hypoxia/ischemia.
37129835	19	29	Ospemifene	Chemical	MESH:C119141
37129835	41	48	Hypoxia	Disease	MESH:D000860
37129835	54	62	Ischemia	Disease	MESH:D007511
37129835	155	161	Stroke	Disease	MESH:D020521
37129835	166	184	perinatal asphyxia	Disease	MESH:D001237
37129835	249	255	deaths	Disease	MESH:D003643
37129835	418	443	cerebrovascular accidents	Disease	MESH:D020521
37129835	619	632	endometriosis	Disease	MESH:D004715
37129835	636	661	hormone-dependent cancers	Disease	MESH:D009369
37129835	701	711	ospemifene	Chemical	MESH:C119141
37129835	731	748	estrogen receptor	Gene	2099
37129835	782	793	dyspareunia	Disease	MESH:D004414
37129835	851	861	ospemifene	Chemical	MESH:C119141
37129835	920	927	hypoxia	Disease	MESH:D000860
37129835	935	943	ischemia	Disease	MESH:D007511
37129835	1015	1025	Ospemifene	Chemical	MESH:C119141
37129835	1045	1052	hypoxia	Disease	MESH:D000860
37129835	1058	1066	ischemia	Disease	MESH:D007511
37129835	1113	1130	neurodegeneration	Disease	MESH:D019636
37129835	1204	1214	ospemifene	Chemical	MESH:C119141
37129835	1281	1290	caspase-3	Gene	836
37129835	1311	1318	hypoxia	Disease	MESH:D000860
37129835	1372	1380	ischemia	Disease	MESH:D007511
37129835	1408	1418	ospemifene	Chemical	MESH:C119141
37129835	1469	1472	BAX	Gene	581
37129835	1474	1477	FAS	Gene	355
37129835	1479	1483	FASL	Gene	356
37129835	1489	1497	GSK3beta	Gene	2932
37129835	1554	1558	BCL2	Gene	596
37129835	1629	1639	ospemifene	Chemical	MESH:C119141
37129835	1664	1668	ESR1	Gene	2099
37129835	1677	1684	hypoxia	Disease	MESH:D000860
37129835	1689	1697	ischemia	Disease	MESH:D007511
37129835	1703	1708	GPER1	Gene	2852
37129835	1717	1724	hypoxia	Disease	MESH:D000860
37129835	1749	1759	ospemifene	Chemical	MESH:C119141
37129835	1780	1784	ESR1	Gene	2099
37129835	1803	1810	hypoxic	Disease	MESH:D002534
37129835	1815	1823	ischemic	Disease	MESH:D002545
37129835	1854	1864	ospemifene	Chemical	MESH:C119141
37129835	1954	1967	brain hypoxia	Disease	MESH:D002534
37129835	1968	1976	ischemia	Disease	MESH:D007511
37129835	Negative_Correlation	MESH:C119141	MESH:D007511
37129835	Positive_Correlation	MESH:C119141	596
37129835	Association	MESH:D002545	2099
37129835	Negative_Correlation	MESH:C119141	MESH:D004414
37129835	Association	MESH:C119141	MESH:D002545
37129835	Negative_Correlation	MESH:C119141	MESH:D002534
37129835	Negative_Correlation	MESH:C119141	355
37129835	Association	MESH:D000860	836
37129835	Negative_Correlation	MESH:C119141	MESH:D000860
37129835	Negative_Correlation	MESH:C119141	581
37129835	Association	MESH:D002534	2099
37129835	Negative_Correlation	MESH:C119141	2932
37129835	Association	MESH:C119141	2852
37129835	Positive_Correlation	MESH:C119141	2099
37129835	Negative_Correlation	MESH:C119141	836
37129835	Negative_Correlation	MESH:C119141	356
37129835	Negative_Correlation	MESH:C119141	MESH:D019636

